title: Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience.
abstract: The aim of the present study was to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in patients with Müllerian carcinoma treated at our hospital. Nineteen patients with platinum-resistant Müllerian carcinoma were treated with intravenous PLD 50 mg/m(2) every 4 weeks. Tumor response was assessed by MRI following every 2-3 cycles of treatment. The severity of adverse events was assessed according to the Common Terminology Criteria for Adverse Events (v3.0). The best overall responses in the 19 patients were identified as 5 partial responses (PR), 6 stable diseases (SD) and 8 progressive diseases (PD). Response rate was 26.3%. The proportion of patients with CR, PR or SD was 57.9%. The median time to progression was 188.0 days. The median survival time was 381.0 days. Toxicity grades were identified as one grade III hand-foot syndrome, two grade III neutropenia, one grade IV hand-foot syndrome, one grade IV stomatitis and one grade IV neutropenia. The present study confirmed that PLD is an effective drug when administered as a salvage therapy for the treatment of Müllerian carcinoma and is associated with a reduced toxicity profile compared with current therapeutic options.
authors.affiliation: Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka 545-8585,  Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Fukuda
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Sumi
authors.forename: Masatomo
authors.initials: M
authors.lastname: Teramae
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Nakano
authors.forename: Masanari
authors.initials: M
authors.lastname: Morishita
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Terada
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yoshida
authors.forename: Yoshinari
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Tomoyo
authors.initials: T
authors.lastname: Yasui
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishiko